The peptide is primarily studied for its potential to influence pigmentation Melanotan-2 (MT-2), a synthetic peptide derived ...
"Our results uncover a mechanism by which the nonvisual opsin receptor OPN3 modulates food intake via the melanocortin 4 ...
GlobalData on MSN21d
Palatin concludes Phase II trial of combination therapy for obesityPalatin Technologies has completed its Phase II study, BMT-801, evaluating the joint administration of melanocortin 4 receptor (MC4R) bremelanotide with tirzepatide, a glucagon-like peptide-1 ...
Hosted on MSN1mon
Palatin gears up for obesity treatment trials in 2025In other recent news, Palatin Technologies has completed the enrollment phase of its Phase 2 clinical trial for PL8177, a melanocortin-1 receptor agonist being tested for ulcerative colitis. The ...
She first joined the Centre for Endocrinology in 2005 to undertake her PhD investigating a novel receptor trafficking protein MRAP2 (melanocortin receptor accessory protein two). This was funded by a ...
Phase 2 obesity co-administration study with MC4R agonist bremelanotide plus GLP-1/GIP dual agonist tirzepatide Database lock completed Topline data readout ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback